Inactivation of HAUSP in vivo modulates p53 function

Kon, N.; Kobayashi, Y.; Li, M.; Brooks, C. L.; Ludwig, T.; Gu, W.
March 2010
Oncogene;3/4/2010, Vol. 29 Issue 9, p1270
Academic Journal
Hausp is a deubiquitinase that has been shown to regulate the p53–Mdm2 pathway. Cotransfection of p53 and Hausp stabilizes p53 through the removal of ubiquitin moieties from polyubiquitinated p53. Interestingly, knockout or RNA interference-mediated knockdown of Hausp in human cells also resulted in the stabilization of p53 due to the destabilization of Mdm2, suggesting a dynamic role of Hausp in p53 activation. To understand the physiological functions of Hausp, we generated hausp knockout mice. Hausp knockout mice die during early embryonic development between embryonic days E6.5 and E7.5. The hausp knockout embryos showed p53 activation, but no apparent increase in apoptosis. Embryonic lethality was caused by a dramatic reduction in proliferation and termination in development, in part due to p53 activation and/or abrogation of p53-independent functions. Although deletion of p53 did not completely rescue the embryonic lethality of the hausp knockout, embryonic development was extended in both hausp and p53 double knockout embryos. These data show that Hausp has a critical role in regulating the p53–Mdm2 pathway.


Related Articles

  • Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response. Marcel, V; Fernandes, K; Terrier, O; Lane, D P; Bourdon, J-C // Cell Death & Differentiation;Sep2014, Vol. 21 Issue 9, p1377 

    In addition to the tumor suppressor p53 protein, also termed p53α, the TP53 gene produces p53β and p53γ through alternative splicing of exons 9β and 9γ located within TP53 intron 9. Here we report that both TG003, a specific inhibitor of Cdc2-like kinases (Clk) that regulates the...

  • The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53. Liu, Hongmei; Li, Xiaoling; Ning, Guozhu; Zhu, Shu; Ma, Xiaolu; Liu, Xiuli; Liu, Chunying; Huang, Min; Schmitt, Ina; Wüllner, Ullrich; Niu, Yamei; Guo, Caixia; Wang, Qiang; Tang, Tie-Shan // PLoS Biology;11/16/2016, Vol. 14 Issue 11, p1 

    As a deubiquitinating enzyme (DUB), the physiological substrates of ataxin-3 (ATX-3) remain elusive, which limits our understanding of its normal cellular function and that of pathogenic mechanism of spinocerebellar ataxia type 3 (SCA3). Here, we identify p53 to be a novel substrate of ATX-3....

  • Ubiquitin-independent p53 proteasomal degradation. Tsvetkov, P.; Reuven, N.; Shaul, Y. // Cell Death & Differentiation;Jan2010, Vol. 17 Issue 1, p103 

    The mechanism of p53 proteasomal degradation through polyubiquitination is well characterized. The basic assumption behind this mechanism is that p53 is inherently stable unless sensitized to degradation by polyubiquitination. However, a number of studies provide evidence for p53 to be naturally...

  • Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-κB pathway. Tinel, Antoine; Janssens, Sophie; Lippens, Saskia; Cuenin, Solange; Logette, Emmanuelle; Jaccard, Bastienne; Quadroni, Manfredo; Tschopp, Jürg // EMBO Journal;1/10/2007, Vol. 26 Issue 1, p197 

    Upon DNA damage, a complex called the PIDDosome is formed and either signals NF-κB activation and thus cell survival or alternatively triggers caspase-2 activation and apoptosis. PIDD (p53-induced protein with a death domain) is constitutively processed giving rise to a 48-kDa N-terminal...

  • p53-Induced Apoptosis and Inhibitors of p53. Nayak, Surendra Kumar; Panesar, Paramjit Singh; Kumar, Harish // Current Medicinal Chemistry;Jul2009, Vol. 16 Issue 21, p2627 

    Protein p53 is a key player in mitochondrial mediated apoptotic cell death and excess p53 activity has been implicated in many disease states such athrosclerosis, diabetes, osteoarthritis, Alzheimer's disease, Parkinson's disease, Huntington's disease, AIDS, P. falciparum and S. typhimurium...

  • Interrelation of Cell Apoptosis and Proliferation in the Thymus during Its Involution. Linkova, N.; Polyakova, V.; Kvetnoy, I. // Bulletin of Experimental Biology & Medicine;Aug2011, Vol. 151 Issue 4, p460 

    In people over 60 years, thymocytes contain proliferation protein Ki67 and proapoptotic protein P53. During aging, apoptosis of thymus cell prevails over proliferation, though thymocytes retain proliferative capacity even in long-livers.

  • Regulation of p53 stability and function by the deubiquitinating enzyme USP42. Hock, Andreas K; Vigneron, Arnaud M; Carter, Stephanie; Ludwig, Robert L; Vousden, Karen H // EMBO Journal;12/14/2011, Vol. 30 Issue 24, p4921 

    The p53 tumour suppressor protein is a transcription factor that prevents oncogenic progression by activating the expression of apoptosis and cell-cycle arrest genes in stressed cells. The stability of p53 is tightly regulated by ubiquitin-dependent degradation, driven mainly by the ubiquitin...

  • P63 regulates tubular formation via epithelial-to-mesenchymal transition. Zhang, Y; Yan, W; Chen, X // Oncogene;3/20/2014, Vol. 33 Issue 12, p1548 

    P63, a p53 family member, is expressed as TA and ΔN isoforms. Interestingly, both TAp63 and ΔNp63 are transcription factors, and regulate both common and distinct sets of target genes. p63 is required for survival of some epithelial cell lineages, and lack of p63 leads to loss of...

  • Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function. Godin-Heymann, Nadia; Wang, Yihua; Slee, Elizabeth; Lu, Xin // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    We reported recently that apoptosis-stimulating protein of p53 (ASPP) 2, an activator of p53, co-operates with oncogenic RAS to enhance the transcription and apoptotic function of p53. However, the detailed mechanism remains unknown. Here we show that ASPP2 is a novel substrate of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics